ILUZANEBART

UNII:	23Q5AU2MD5
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ILUZANEBART
GSRS Full Record:	23Q5AU2MD5 i

2733621-19-5
ILUZANEBART [USAN]
Iluzanebart
Immunoglobulin G1 [296-cysteine,301-glycine,306-cysteine], anti-(human triggering receptor expressed on myeloid cells 2) (human monoclonal VGL101 γ1-chain), disulfide with human monoclonal VGL101 κ-chain, dimer
VGL-101
VGL101
gamma1 heavy chain Homo sapiens (1-451) [VH (Homo sapiens IGHV5-51*01 (96.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, G1v54-30 CH2 C83, G84.4, C85 (CH1 R120>K (218) (122-219), hinge 1-15 (220-234), CH2 R83>C (296), N84.4>G (301), V85>C(306) (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450- 451)) (122-451)], (224-214')-disulfide with kappa light chain Homo sapiens (1'-214') [V-KAPPA (Homo sapiens IGKV3-15*01 (94.7%)-IGKJ1*01 (90.9%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo sapiens IGKC*01 (100%) (108'-214')]; dimer (230- 230'':233-233'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
iluzanebart [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ILUZANEBART

Synonyms and Mappings

Resources